Insights
Scientific Research
Real-World Data Analysis of First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor (EGFR-TKI) Compared to Clinical Trials Using Danny Platform
July 2025, Expert Review of Pharmacoeconomics & Outcomes Research, an esteemed peer-reviewed journal published by Taylor & Francis Group, released the article titled “Real-world evidence of first-line Osimertinib...
Highlights
Why Investing in Real-World Data (RWD) Matters for Hospitals and Pharma
As healthcare evolves toward more personalized, efficient, and outcomes-driven models, real-world data (RWD) is becoming a cornerstone of transformation. For both hospitals and pharmaceutical companies,...
Highlights
Transforming “raw” real-world data into “analyzable” real-world data with Danny Platform
How Sqilline Health support the EU data quality framework? The use of real-world data (RWD) for healthcare decision-making is complicated by concerns regarding whether RWD...